Endocrine Abstracts

Introduction: Neuroendocrine tumors (NET) are heterogenous tumors with variable survival and the frequently occurring ability to metastasize. A basis for metastasis of tumors is invasive growth. One factor participating in this process is the existence of the so called ‘circulating tumor cells’ (CTC) in the peripheral blood. Up to now there is only rare data available regarding the number of CTCs in NET patients.Methods: EpCAM protein expressio...

Despite their nature of being clinically inapparent, subtle laboratory abnormalities are sometimes detected in patients with adrenal incidentalomas and the question arises whether these changes justify surgical intervention in a patient with an otherwise benign adrenal tumour. Therefore, we aimed at finding further expressions of adrenal hormone excess that reflect net glucocorticoid action.Since glucocorticoids are potent immune suppressants we studied ...

Autonomy of ACTH secretion has been described in patients with chronic dysinhibition of ACTH secretion. We here present the very unusual case of a 31-year old female patient who had congenital adrenal hyperplasia and developed Cushing’s disease, including clinical examinations, laboratory data, endocrine function tests, histological and genetic analyses.The affected patient had clinical signs and a typical history of hypercortisolism. Endocrine func...

The mechanisms that lead to tumor formation of and aldosterone secretion by zona glomerulosa cells in primary aldosteronism are not known. Recently, endothelial cell-derived factors have been characterized that control the release of aldosterone by adrenocortical cells. In addition, we started to characterize the regulation of CITED2, a CBP/p300 interacting transactivator with ED-rich tail 2. Earlier, it was shown in mice that absence of CITED2 leads to adrenal agenesis. Since...